サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1212515

コレステロール検査の世界市場 2023

Cholesterol Testing
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 273 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.42円
コレステロール検査の世界市場 2023
出版日: 2023年01月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 273 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

コレステロール検査の世界市場は、2030年に317億米ドルに達する

変化したCOVID-19後のビジネス環境において、2022年に220億米ドルと推定されるコレステロール検査の世界市場は、2030年までに317億米ドルの修正規模に達し、分析期間2022-2030年に4.7%のCAGRで成長すると予測しています。本レポートで分析したセグメントの1つである診断センターは、CAGR5.9%を記録し、分析期間終了時には116億米ドルに達すると予測されます。パンデミック後の回復を考慮し、医師/プロバイダー/病院分野の成長は、今後8年間のCAGRが4.6%に修正されました。

米国市場は64億米ドル、中国はCAGR8%で成長予測

米国のコレステロール検査市場は、2022年に64億米ドルと推定されます。世界第2位の経済大国である中国は、2022年から2030年にかけてCAGR8%で推移し、2030年までに59億米ドルの市場規模に達すると予測されています。その他の注目すべき地域市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ1.6％と5.3％の成長が予測されています。欧州では、ドイツがCAGR2.5%で成長すると予測されています。オーストラリア、インド、韓国などの国々が牽引するアジア太平洋地域の市場は、2030年までに44億米ドルに達すると予測されています。

調査対象企業の例

  • Abbott Laboratories
  • AccuTech LLC
  • Akers Biosciences Inc.
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • Boston Heart Diagnostics Corporation
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd.
  • Home Access Health Corporation
  • Laboratory Corporation of America（R）Holdings
  • PTS Diagnostics
  • Quest Diagnostics Inc.
  • Randox Laboratories Ltd.
  • Sekisui Diagnostics LLC
  • Siemens Healthineers
  • Sigma-Aldrich Corp.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP-3403

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Cholesterol Testing Market to Reach $31.7 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Cholesterol Testing estimated at US$22 Billion in the year 2022, is projected to reach a revised size of US$31.7 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2022-2030. Diagnostic Centers, one of the segments analyzed in the report, is projected to record a 5.9% CAGR and reach US$11.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Physicians / Providers & Hospitals segment is readjusted to a revised 4.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $6.4 Billion, While China is Forecast to Grow at 8% CAGR

The Cholesterol Testing market in the U.S. is estimated at US$6.4 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.9 Billion by the year 2030 trailing a CAGR of 8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.6% and 5.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$4.4 Billion by the year 2030.

Select Competitors (Total 42 Featured):

  • Abbott Laboratories
  • AccuTech LLC
  • Akers Biosciences Inc.
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • Boston Heart Diagnostics Corporation
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd.
  • Home Access Health Corporation
  • Laboratory Corporation of America® Holdings
  • PTS Diagnostics
  • Quest Diagnostics Inc.
  • Randox Laboratories Ltd.
  • Sekisui Diagnostics LLC
  • Siemens Healthineers
  • Sigma-Aldrich Corp.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Cholesterol Testing - An Overview
    • Recent Market Activity
    • Prevailing Scenario in the Global Healthcare Sector Favors Market Growth
    • Increasing Healthcare Expenditure
    • Wider Availability of Healthcare & Diagnostics Services
    • Growing Health-Consciousness
    • Lenience Towards Preventive Care
    • Cholesterol Testing - Global Key Competitors Percentage Market Share in 2022 (E)
    • Developed Regions Remain Key Revenue Contributors
    • Developing Economies Offer Significant Potential
    • Key Factors Driving Demand for Healthcare Services in Developing Regions
    • Impact of Covid-19 and a Looming Global Recession
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
    • Abbott Laboratories (USA)
    • AccuTech, LLC (USA)
    • Akers Biosciences, Inc. (USA)
    • Beckman Coulter, Inc. (USA)
    • Bio-Rad Laboratories, Inc. (USA)
    • Eurofins Scientific (Luxembourg)
    • Boston Heart Diagnostics Corporation (USA)
    • F. Hoffmann-La Roche Ltd. (Switzerland)
    • Home Access Health Corporation (USA)
    • Laboratory Corporation of America® Holdings (USA)
    • PRIMA Lab SA (Switzerland)
    • PTS Diagnostics (USA)
    • Quest Diagnostics, Inc. (USA)
    • Randox Laboratories Ltd. (UK)
    • Sekisui Diagnostics, LLC (USA)
    • Siemens Healthineers (Germany)
    • Sigma-Aldrich Corp. (USA)
  • 3. MARKET TRENDS & DRIVERS
    • Growing Prevalence of Cardiovascular Disease Steers Cholesterol Testing Volumes
    • Global Menace of Cardiovascular Disease: Quick Facts
    • A Brief Overview of Select Cholesterol-Driven Cardiac Disorders
    • Coronary Artery Disease
    • Hyperlipidaemia
    • CVD Statistics
    • Risk of CVD in Obese People Underpins Cholesterol Testing Volumes
    • Global Obesity Facts in a Nutshell
    • Cholesterol Screening Assumes Importance in Diabetes Care
    • Global Diabetes Expenditure: Opportunity Indicator
    • The Hypertension-Cholesterol Link Accelerates the Need for Cholesterol Screening
    • Aging Population - A Vital Demography
    • Uptrend in In-Vitro Diagnostics (IVD) Sector Signals Prospects
    • Healthy Growth in Cardiac IVD Market Augments Market Potential
    • Positive Momentum in Point of Care (POC) Diagnostics Generates Parallel Opportunities
    • POC Diagnostics - An Overview
    • POC Cholesterol Testing Makes Rapid Gains
    • Massive Demand for Lipid Panel/Lipid Profile Tests
    • Northbound Trajectory in POC LPT Services
    • Rise of C-reactive Protein Tests to Aid Market Growth
    • Cholesterol Testing: Evolution from Invasive to Non-Invasive
    • Recent Breakthroughs in Non-Invasive Cholesterol Testing Domain
    • Nonfasting Lipid Testing Invalidates the Need for Pre-Test Fasting
    • Cloud Screening Platforms Extend New Level of Convenience
    • Self-Testing Kits: An Emerging Issue for Full-Scale Services Providers
    • A Rapidly Evolving Market Enabled by Technology
    • Opportunities & Challenges in Self-Testing Industry
    • E-Retailing Drives Sales of Home Test Kits
    • A Brief Overview of Select Cholesterol Test Kits
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Cholesterol Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 3: World 18-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 6: World 18-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Physicians / Providers & Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Physicians / Providers & Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 9: World 18-Year Perspective for Physicians / Providers & Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Government Agencies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Government Agencies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 12: World 18-Year Perspective for Government Agencies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
    • TABLE 13: World Cholesterol Testing Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 16: USA 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 19: Canada 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • JAPAN
    • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 22: Japan 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • CHINA
    • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 25: China 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • EUROPE
    • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Cholesterol Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 28: Europe 18-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2023 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 31: Europe 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • FRANCE
    • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 34: France 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • GERMANY
    • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 37: Germany 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 40: Italy 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • UNITED KINGDOM
    • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 43: UK 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 46: Spain 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 49: Russia 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 52: Rest of Europe 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • ASIA-PACIFIC
    • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Cholesterol Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 55: Asia-Pacific 18-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2023 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 58: Asia-Pacific 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • AUSTRALIA
    • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 61: Australia 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • INDIA
    • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 64: India 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 67: South Korea 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • LATIN AMERICA
    • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Cholesterol Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 73: Latin America 18-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2023 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 76: Latin America 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 79: Argentina 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 82: Brazil 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 85: Mexico 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 88: Rest of Latin America 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • MIDDLE EAST
    • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Cholesterol Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 91: Middle East 18-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2023 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 94: Middle East 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 97: Iran 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 100: Israel 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 103: Saudi Arabia 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 106: UAE 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 109: Rest of Middle East 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
  • AFRICA
    • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 112: Africa 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030

IV. COMPETITION